YFG-33617-61198 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-29
Dose 1 — Pfizer-BioNTech
2021-05-20
Dose 2 — Pfizer-BioNTech
2021-12-06
Dose 3 — Pfizer-BioNTech
2021-12-18
Registered in v-safe
2021-12-18
Health check-in — day 7, dose 3
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-12-20
Survey response — day 14, dose 3
MedDRA: Rash — Feeling: Good

Free text: Rash continues to spread to back and shoulder blade and lower arms but overall slower pace

MedDRA releases: 2024-11 · check-in free text available
2021-12-28
Survey response — day 21, dose 3
MedDRA: Pruritus, Pruritus genital, Rash, Scab, Skin discolouration — Feeling: Good

Free text: Skin rash is getting to sever. Itching is still mild but it's now spreading below the waistline including genitalia. The rash is still mostly concentrated on stomach and lightly scabs over causing skin discoloration. I may need to seek care now

MedDRA releases: 2024-11 · check-in free text available
2022-01-05
Survey response — day 28, dose 3
MedDRA: Pigmentation disorder, Rash, Skin discolouration — Feeling: Good

Free text: Skin rash continues to spread across my body. Expanding up the torso and down below the waist. However the oldest rashes around the stomach and lower arms have showed signs of healing. Though they leave behind dark pigment spots.

MedDRA releases: 2024-11 · check-in free text available
2022-01-12
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-18
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-09
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-06
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-06
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-29	Pfizer-BioNTech	No
2	2021-05-20	Pfizer-BioNTech	No
3	2021-12-06	Pfizer-BioNTech	No

Free text

Release 10 — day 14, dose 3

2021-12-20

Symptoms: Rash continues to spread to back and shoulder blade and lower arms but overall slower pace

Release 10 — day 21, dose 3

2021-12-28

Symptoms: Skin rash is getting to sever. Itching is still mild but it's now spreading below the waistline including genitalia. The rash is still mostly concentrated on stomach and lightly scabs over causing skin discoloration. I may need to seek care now

Release 10 — day 28, dose 3

2022-01-05

Symptoms: Skin rash continues to spread across my body. Expanding up the torso and down below the waist. However the oldest rashes around the stomach and lower arms have showed signs of healing. Though they leave behind dark pigment spots.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pigmentation disorder	·	·	✓
SD	Pruritus	·	·	✓
SD	Pruritus genital	·	·	✓
SD	Rash	·	·	✓
SD	Scab	·	·	✓
SD	Skin discolouration	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release